Boehringer reps win overtime ruling

Boehringer-Ingelheim sales reps may be awarded back pay for all unpaid overtime they've worked, after a legal victory in a Connecticut federal court; the ruling could also affect cases involving reps at Amgen and Serono, BNet Pharma reports. Report

Suggested Articles

Pfizer has scored FDA approval for its Humira biosimilar, but it can't launch the product for several years under a patent settlement.

The 3-2 vote on the deal was split along the party lines, spelling trouble for future biopharma M&A deals should Democrats move into the White House.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.